Sustainable One-Pot Synthesis of Novel Triazolopyrimidine Derivatives as Selective CDK4 Inhibitors for Breast Cancer Therapy.

Saved in:
Bibliographic Details
Title: Sustainable One-Pot Synthesis of Novel Triazolopyrimidine Derivatives as Selective CDK4 Inhibitors for Breast Cancer Therapy.
Authors: Elsayed DA; Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, Egypt., Shehab WS; Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, Egypt., Mohamed MM; Viral Media Lab, Egyptian Organization for Biological Products & Vaccines (VACSERA), Giza, Egypt.; Department of Medical Laboratory Techniques, Al-Farahidi University, Baghdad, Iraq., Mesbah AE; Department of Chemistry, Faculty of Science, Mansoura University, Mansoura, Egypt., El-Bassyouni GT; Refractories, Ceramics and Building Materials Department, National Research Centre, Cairo, Egypt., Mousa SM; Inorganic Chemistry Department, National Research Centre, Cairo, Egypt., Abo Elenin OM; Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, Egypt., Assy MG; Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, Egypt., Tantawy ES; Department of Chemistry, Faculty of Science, Zagazig University, Zagazig, Egypt.
Source: Drug development research [Drug Dev Res] 2026 Jun; Vol. 87 (4), pp. e70322.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8204468 Publication Model: Print Cited Medium: Internet ISSN: 1098-2299 (Electronic) Linking ISSN: 02724391 NLM ISO Abbreviation: Drug Dev Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1098-2299
DOI:10.1002/ddr.70322